SCHEMBL8229265

SCHEMBL8229265

OCCCCC(O)(c1ccccc1)C1CCOC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 5/20 0.40
CHRM2 P08172 4/20 0.40
CHRM1 P11229 4/20 0.40
CHRM3 P20309 3/20 0.40
KCNH2 Q12809 3/20 0.40
CHRM4 P08173 2/20 0.40
CHRM5 P08912 2/20 0.40
HRH1 P35367 2/20 0.40
TSHR P16473 2/20 0.40
GRIN2D O15399 1/20 0.40
GRIN3B O60391 1/20 0.40
GRIN1 Q05586 1/20 0.40
GRIN2A Q12879 1/20 0.40
GRIN2B Q13224 1/20 0.40
GRIN2C Q14957 1/20 0.40
GRIN3A Q8TCU5 1/20 0.40
CYP3A4 P08684 1/20 0.40
NFKB1 P19838 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
HTR1A P08908 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1017886 0.72 CYP2D6 (0.43) CYP2D6CHRM3KCNH2HRH1CYP3A4
SCHEMBL1008632 0.71 LMNA (0.42) CYP2D6CHRM3KCNH2HRH1TSHR
SCHEMBL6048472 0.66 SIGMAR1 (0.58) CYP2D6CHRM2CHRM1CHRM3KCNH2
SCHEMBL13145313 0.66 CHRM2 (0.35) CYP2D6CHRM2CHRM1CHRM3KCNH2
SCHEMBL28979281 0.65 LMNA (0.46) CYP2D6CHRM3HRH1CYP3A4MEN1
SCHEMBL9910958 0.65 CHRM2 (0.68) CYP2D6CHRM2CHRM1CHRM3KCNH2
SCHEMBL7438216 0.65 LMNA (0.55) CYP2D6CHRM2CHRM1CHRM3KCNH2
SCHEMBL10390945 0.65 CHRM2 (0.61) CYP2D6CHRM2CHRM1CHRM3KCNH2
SCHEMBL7453762 0.64 KIF11 (0.59) CYP2D6CHRM2CHRM1CHRM3KCNH2
SCHEMBL2006125 0.64 CHRM4 (0.56) CYP2D6CHRM2CHRM1CHRM3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007117557-A2 DIAMINOPROPANOL RENIN INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2007-10-18 WO disclosed